Smith, L. et al. 2016. The New Face of Hyperlipidemia Management: Proprotein Convertase Subtilisin/Kexin Inhibitors (PCSK-9) and Their Emergent Role As An Alternative To Statin Therapy. Journal of Pharmacy & Pharmaceutical Sciences. 19, 1 (Mar. 2016), 137–146. DOI:https://doi.org/10.18433/J3J02P.